IQVIA

Articles

Through Obstacles and Beyond: The Value of Building Strategic Site Relationships

May 04, 2021

*** Wednesday, May 4, 2021 at 11am EDT *** Driving faster site activation for any clinical trial requires close interactions with sponsors to seamlessly execute a breadth of requirements to stay compliant while delivering to new levels of efficiencies ***On demand available after final airing until May 4, 2022***

Trials and Tribulations of Electronic Patient Consent: Removing Barriers to eConsent Adoption

April 28, 2021

*** Wednesday, April 28, 2021 at 11am EDT *** After a decade of dabbling with eConsent, it’s time for sponsors and technology providers to meet the demand to bring clinical trials directly to the patient at a global scale. Join this webinar to learn how to overcome the persistent challenges in eConsent adoption and deliver the promise of decentralized trials. ***On demand available after final airing until Apr. 28, 2022***

RBM Case Studies: AI-ML Implementation and Shifts in Clinical Operating Models – Defining monitoring of the future

April 05, 2021

*** Monday, April 5, 2021 at 11am EDT *** Risk-based monitoring (RBM) continues to evolve and adapt to industry needs. Understand how innovative technologies and methodologies are driving new levels of study quality and changing clinical monitoring and how artificial intelligence, machine learning, predictive and advanced analytics are improving patient safety and overall study quality and operational efficiencies. ***On demand available after final airing until Apr. 5, 2022***

Clinical Development of Oncology Products in Japan – the 2nd Largest Market for Innovation

November 19, 2020

*** Thursday, November 19, 2020 | 4:00 pm-5:00 pm EST ***Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. In addition, the Japanese market is driven by ongoing regulatory and government initiatives that reward innovation, shifts in population demographics, and increased disease awareness, and identifiable patient populations, amongst other factors. ***On demand available after final airing until Nov. 19, 2021***